Abstract:Tumorigenesis is always concomitant with microenvironmental alterations. The tumor microenvironment is a heterogeneous and complex milieu, which exerts a variety of stresses on tumor cells for proliferation, survival, or death. Recently, accumulated evidence revealed that metabolic and oxidative stresses both play significant roles in tumor development and progression that converge on a common autophagic pathway. Tumor cells display increased metabolic autonomy, and the hallmark is the exploitation of aerobic glycolysis (termed Warburg effect), which increased glucose consumption and decreased oxidative phosphorylation to support growth and proliferation. This characteristic renders cancer cells more aggressive; they devour tremendous amounts of nutrients from microenvironment to result in an ever-growing appetite for new tumor vessel formation and the release of more "waste," including key determinants of cell fate like lactate and reactive oxygen species (ROS). The intracellular ROS level of cancer cells can also be modulated by a variety of stimuli in the tumor microenvironment, such as pro-growth and pro-inflammatory factors. The intracellular redox state serves as a double-edged sword in tumor development and progression: ROS overproduction results in cytotoxic effects and might lead to apoptotic cell death, whereas certain level of ROS can act as a second-messenger for regulation of such cellular processes as cell survival, proliferation, and metastasis. The molecular mechanisms for cancer cell responses to metabolic and oxidative stresses are complex and are likely to involve multiple molecules or signaling pathways. In addition, the expression and modification of these proteins after metabolic or oxidative stress challenge are diverse in different cancer cells and endow them with different functions. Therefore, MS-based high-throughput platforms, such as proteomics, are indispensable in the global analysis of cancer cell responses to metabolic and oxidative stress. Herein, we highlight recent advances in the understanding of the metabolic and oxidative stresses associated with tumor progression with proteomics-based systems biology approaches.

SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8<SUP>+</SUP>T cells

SENP3 Senses Oxidative Stress to Facilitate STING-dependent Dendritic Cell Antitumor Function

Oxidized Lipids and CD36-Mediated Lipid Peroxidation in CD8 T Cells Suppress Anti-Tumor Immune Responses

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

The Responses of SENP3 to Different Extents of Oxidative Stress

SENP3 Maintains the Stability and Function of Regulatory T Cells Via BACH2 Desumoylation

PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Role Of Sumo-Specific Protease 2 In Reprogramming Cellular Glucose Metabolism

Senescent cells develop PDK4-dependent hypercatabolism and form an acidic microenvironment to drive cancer resistance

PTEN Nuclear Localization is Regulated by Oxidative Stress and Mediates P53-Dependent Tumor Suppression

Resilient CD8+ T cells maintain a high cytotoxic capacity by balancing ROS via ME1 upregulation

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

Sentrin/small ubiquitin-like modifier-specific protease 5 protects oral cancer cells from oxidative stress-induced apoptosis.

Senescent cells develop PDK4-dependent hypercatabolism and produce lactate to promote cancer resistance and aging

Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis

Resilient CD8 +T cells maintain a high cytotoxic capacity by balancing ROS and energy needs via ME1 upregulation

Selective oxidative stress induces dual damage to telomeres and mitochondria in human T cells

SUMOylation of the Ubiquitin Ligase Component KEAP1 at K39 Upregulates NRF2 and Its Target Function in Lung Cancer Cell Proliferation.

Metabolic reprogramming of antitumor CD8+ T cells by modulation of GSH-Gpx4 axis